Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

77242113PSO3005: 77242113PSO3005 Ph III Trial Local Study (N=20) {EP/GPP}

NCT06295692 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.

NCT NCT06295692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06295692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
77242113PSO3005: 77242113PSO3005 Ph III Trial Local Study (N=20) {EP/GPP}
Lead sponsor
Janssen Pharmaceutical K.K.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 9, 2024
Completion date
October 14, 2027
Enrollment
19 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

erythrodermic psoriasis, generalized pustular psoriasis